UNIVERSITY OF NEW MEXICO

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1889-01-01

Employees: 6.7K

Market Cap: -

Website: https://www.unm.edu/

Clinical Trials

Timing of Insulin Before Meals Everyday

Not Applicable

Terminated

Conditions: Type 1 Diabetes

Interventions: Other: Study Arm B
Other: Control

First Posted Date: 2008-11-13

Last Posted Date: 2024-08-28

Lead Sponsor: University of New Mexico

Target Recruit Count: 76

Registration Number: NCT00789945

Locations: 🇺🇸
UNM HSC Diabetes Research and Treatment Center, Albuquerque, New Mexico, United States
🇺🇸
Unm Hsc Gcrc, Albuquerque, New Mexico, United States

Caffeine Reduction and Overactive Bladder Symptoms

Not Applicable

Terminated

Conditions: Overactive Bladder

Interventions: Behavioral: Caffeine reduction

First Posted Date: 2008-09-17

Last Posted Date: 2024-01-11

Lead Sponsor: University of New Mexico

Target Recruit Count: 42

Registration Number: NCT00754260

Locations: 🇺🇸
Dr. Kammerer- Doak, Albuquerque, New Mexico, United States
🇺🇸
Tola Omotosho , MD, Albuquerque, New Mexico, United States

Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder

Phase 4

Completed

Conditions: Anxiety Disorder
Alcohol Dependence

Interventions: Drug: disulfiram plus lorazepam

First Posted Date: 2008-07-24

Last Posted Date: 2023-08-30

Lead Sponsor: University of New Mexico

Target Recruit Count: 41

Registration Number: NCT00721526

Locations: 🇺🇸
University of New Mexico Addiction and Substance Abuse Programs, Albuquerque, New Mexico, United States

A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients

Not Applicable

Completed

Conditions: Congestive Heart Failure

Interventions: Drug: Treatment of Furosemide + Hydrochlorothiazide
Drug: Treatment of Furosemide + Metolazone

First Posted Date: 2008-06-04

Last Posted Date: 2024-10-10

Lead Sponsor: University of New Mexico

Target Recruit Count: 8

Registration Number: NCT00690521

Locations: 🇺🇸
University Of New Mexico Hospital, Albuquerque, New Mexico, United States

Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)

Phase 3

Withdrawn

Conditions: Exercise-induced Bronchospasm

Interventions: Drug: placebo
Drug: arformoterol
Drug: formoterol

First Posted Date: 2008-04-21

Last Posted Date: 2015-12-11

Lead Sponsor: University of New Mexico

Registration Number: NCT00662779

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Drug: Insulin Detemir
Drug: Insulin Glargine

First Posted Date: 2008-04-16

Last Posted Date: 2018-03-22

Lead Sponsor: University of New Mexico

Target Recruit Count: 10

Registration Number: NCT00659165

Locations: 🇺🇸
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

Not Applicable

Withdrawn

Conditions: Hypertension

Interventions: Drug: Amlodipine and Hydrocholorothiazide

First Posted Date: 2008-04-11

Last Posted Date: 2023-07-11

Lead Sponsor: University of New Mexico

Registration Number: NCT00656331

Locations: 🇺🇸
UNMHSC, Albuquerque, New Mexico, United States

Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE)

Phase 4

Withdrawn

Conditions: Alcohol Dependence

Interventions: Drug: Acamprosate (Campral)
Drug: Acamprosate

First Posted Date: 2008-04-10

Last Posted Date: 2023-08-01

Lead Sponsor: University of New Mexico

Registration Number: NCT00655967

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Prevention of Post Operative Bone Loss in Children

Not Applicable

Completed

Conditions: Osteoporosis
Spina Bifida
Cerebral Palsy
Osteogenesis Imperfecta
Osteopenia

Interventions: Other: saline
Drug: pamidronate

First Posted Date: 2008-04-10

Last Posted Date: 2023-08-22

Lead Sponsor: University of New Mexico

Target Recruit Count: 24

Registration Number: NCT00655681

Locations: 🇺🇸
University of New Mexico Carrie Tingley Hospital, Albuquerque, New Mexico, United States

Reciprocating Medical Devices - a Study of a New Safety Device

Not Applicable

Completed

Conditions: Osteoarthritis
Rheumatoid Arthritis
Trauma
Thyroid Nodule
Cancer

Interventions: Device: Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001
Device: conventional syringe - BD Ref 309604

First Posted Date: 2008-04-03

Last Posted Date: 2016-03-02

Lead Sponsor: University of New Mexico

Target Recruit Count: 437

Registration Number: NCT00651625

Locations: 🇺🇸
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy